Cancer Nanotechnology : Impact Factor & More
eISSN: 1868-6966pISSN: 1868-6958
Open AccessShare this on:
Key Metrics
CiteScore 
6.8
Eigenfactor
< 0.001
H-Index
32
Impact Factor
5 - 10
SJR
Q1Oncology
SNIP
1.39
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Nanotechnology
Cancer Nanotechnology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 1590 | USD 1890 | GBP 1340 |
| Publication Time | 15 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
Planning to publish in Cancer Nanotechnology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Nanotechnology
Metal–organic framework-based therapeutic strategies for hepatocellular carcinoma: current advances and future perspectives
- 28 Jul 2026
- Cancer Nanotechnology
Correction: Radiation-synthesized naringin-loaded PEG-Au nanocomposite induces autophagy and suppresses hepatocellular carcinoma in rats via modulation of the PI3K/Akt/mTOR downstream beclin-1/ATG2A pathway
- 25 Jul 2026
- Cancer Nanotechnology
Liposomal nanocarriers in retinoblastoma: from molecular design to clinical translation
- 19 Jul 2026
- Cancer Nanotechnology
Sodium new houttuyfonate and doxorubicin co-loaded liposomes for the treatment of cervical cancer
- 21 Jun 2026
- Cancer Nanotechnology
Nanotechnology in oral cancer: a theranostic approach for diagnosis, targeted therapy, and clinical translation
- 16 May 2026
- Cancer Nanotechnology
Targeting glycoprotein VI (GPVI) in cancer: mechanistic insights and therapeutic strategies to suppress metastasis and thrombosis
- 5 May 2026
- Cancer Nanotechnology
Metal–organic framework-based therapeutic strategies for hepatocellular carcinoma: current advances and future perspectives
- 28 Jul 2026
- Cancer Nanotechnology
Correction: Radiation-synthesized naringin-loaded PEG-Au nanocomposite induces autophagy and suppresses hepatocellular carcinoma in rats via modulation of the PI3K/Akt/mTOR downstream beclin-1/ATG2A pathway
- 25 Jul 2026
- Cancer Nanotechnology
Liposomal nanocarriers in retinoblastoma: from molecular design to clinical translation
- 19 Jul 2026
- Cancer Nanotechnology
Sodium new houttuyfonate and doxorubicin co-loaded liposomes for the treatment of cervical cancer
- 21 Jun 2026
- Cancer Nanotechnology
Nanotechnology in oral cancer: a theranostic approach for diagnosis, targeted therapy, and clinical translation
- 16 May 2026
- Cancer Nanotechnology
Targeting glycoprotein VI (GPVI) in cancer: mechanistic insights and therapeutic strategies to suppress metastasis and thrombosis
- 5 May 2026
- Cancer Nanotechnology
FAQs on Cancer Nanotechnology
How long has Cancer Nanotechnology been actively publishing? 
What is the publishing frequency of Cancer Nanotechnology?
How many articles did Cancer Nanotechnology publish last year?
What is the eISSN & pISSN for Cancer Nanotechnology?
What is Citescore for Cancer Nanotechnology?
What is the H Index for Cancer Nanotechnology ?
What is SNIP score for Cancer Nanotechnology?
What is the SJR for Cancer Nanotechnology?
Who is the publisher of Cancer Nanotechnology?
